Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Pyrimethamine |
| Synonyms | |
| Therapy Description |
Daraprim (pyrimethamine) inhibits DHFR, potentially leading to cell cycle arrest and decreased proliferation of tumor cells and inhibition of tumor growth (PMID: 35262820, PMID: 34921584). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Pyrimethamine | Daraprim | Daraprim (pyrimethamine) inhibits DHFR, potentially leading to cell cycle arrest and decreased proliferation of tumor cells and inhibition of tumor growth (PMID: 35262820, PMID: 34921584). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05678348 | Phase I | Pyrimethamine | Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma | Completed | USA | 0 |